Intrinsic Value of S&P & Nasdaq Contact Us

Scinai Immunotherapeutics Ltd. SCNI NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • IL • USD

SharesGrow Score
57/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

There have been 11 recent insider transactions recorded for Scinai Immunotherapeutics Ltd. (SCNI), including 0 buys and 3 sells. Total insider buying was valued at RSU Award and total insider selling at $256.82K.

Notable insiders with recent activity include Raviv Adi, Germain Mark, Moed Samuel J. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — SCNI

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-03-18 Raviv Adi Director Unknown 48,200,000 $0.00 $19.28K -
2026-03-18 Germain Mark Director Unknown 100,000,000 $0.00 $40K -
2026-03-18 Moed Samuel J Director Unknown 48,200,000 $0.00 $19.28K -
2026-03-18 Ben-or Uri Director Unknown 2,519,344 - - -
2026-03-18 Margolin Yael Director Unknown 48,200,000 $0.00 $19.28K -
2026-03-18 Reichman Amir Chief Executive Officer Unknown 67,540,000 - - -
2026-03-18 Green Jay Director Unknown 48,200,000 $0.00 $19.28K -
2026-03-18 Mark Elad Chief Operating Officer Unknown 13,460,984 - - -
2005-09-28 Barron Partners Lp 10 Percent Owner Informative Sell 547,323 $0.46 $251.77K -
2005-09-26 Barron Partners Lp 10 Percent Owner Informative Sell 5,000 $0.50 $2.5K 547,323
2005-09-23 Barron Partners Lp 10 Percent Owner Informative Sell 5,000 $0.51 $2.55K 552,323
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message